Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed and patented platform. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and oncology. The business is located around the Nordic market. The company was founded in 2012 and is headquartered in Solna.

Quotes for Abera Bioscience AB

Right Now

+/-
-0.26
%
-3,27%
Latest
7.7
High
7.75
Low
7.46
Volume
2 656
Turnover (SEK)
20 291
Market Value (MSEK)
89,1
Time (Latest trade)

Board

CEO

  • Maria Alriksson

Chairperson of the Board

  • Anders Ericsson

Board

  • Cristina Glad
  • Florence Vicaire
  • Fredrik Juserius

Videos

Largest Owners

Name Capital % Votes % Date
Nordnet Pensionsförsäkring 13,31 13,31 2022-03-31
Avanza Pension 12,50 12,50 2022-03-31
Anders Ericsson 6,18 6,18 2022-05-17
Jan-Willem De Gier 5,16 5,16 2022-03-31
Joen Luirink 5,04 5,04 2022-03-31
John Moll 4,90 4,90 2021-02-08
Magnus Linderoth 4,49 4,49 2022-03-31
Johan Källstrand 3,50 3,50 2022-03-31
Anders Wall Stiftelser 2,77 2,77 2022-03-31
Mårten Hellberg 2,28 2,28 2021-02-08
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-08-16 Delårsrapport 2022-Q2

  • 2022-11-10 Delårsrapport 2022-Q3

  • 2023-02-23 Bokslutskommuniké 2022